Market Price

16.88 

-0.02 -0.1%

as of Jun 22 '21

52 Week Range:

10.15 17.52


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

SOL S.p.A. engages in the applied research, production, and distribution of industrial, pure, and medicinal gases; and in door-to-door medical care and related medical equipment in Italy and internationally. It offers technical and medical gases, including oxygen, nitrogen, argon, hydrogen, carbon dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium, as well as synthetic and compressed air; gas for electronics; ammonia and combustible gases for industrial use; gases and gas mixtures for respiratory and therapeutic, and diagnostic and instrumental use; and special gases and gas mixtures. The company also provides services, apparatus, and products for home oxygen therapy, home mechanical ventilation, home artificial feeding, and home treatment of bed sores; home treatment services for nocturnal apnoea syndrome; and integrated homecare services. In addition, it produces hydroelectric power; and engages in the exploration and identification, design, construction, and running of hydroelectric power stations connected to the national high tension distribution network. Further, the company designs, constructs, and manages bio banks, cell factories, and centers for processing and conserving cells and tissues; offers pre-and post-natal diagnostic services; and produces and sells diagnostic systems and services. Additionally, it is involved in the GMP production of monoclonal antibodies and recombinant proteins; and scientific, pre-clinical, and clinical research of biological pharmaceuticals, as well as the provision of transport and biological sample conservation services for third parties. SOL S.p.A. products are used in the chemical, electronics, iron and steel, engineering, and foodstuff industries, as well as in environmental protection, and research and health sectors. The company was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. is a subsidiary of Gas and Technologies World BV.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 3.78
4.02
4.15
4.23
growth rate 6.4% 3.2% 1.9%
Earnings BIT 52.50
49.77
46.51
49.96
58.09
61.54
75.30
68.82
85.63
91.79
130.11
growth rate -5.2% -6.6% 7.4% 16.3% 5.9% 22.4% -8.6% 24.4% 7.2% 41.8%
Avg.PE 14.01
11.95
12.50
23.87
24.43
23.34
26.13
23.70
20.73
20.22
14.51
growth rate -14.7% 4.6% 91.0% 2.4% -4.5% 12.0% -9.3% -12.5% -2.5% -28.2%
ROA 4.97
4.48
3.87
2.76
growth rate -9.9% -13.6% -28.7%
ROE 9.63
8.81
7.82
5.68
growth rate -8.5% -11.2% -27.4%
ROIC 10.46
10.60
4.84
5.60
growth rate 1.3% -54.3% 15.7%
Cur. Ratio 2.17
2.23
2.58
2.42
growth rate 2.8% 15.7% -6.2%
Quick Ratio 1.84
0.31
2.16
2.04
growth rate -83.2% 596.8% -5.6%
Leverage 1.92
2.01
2.03
2.09
growth rate 4.7% 1.0% 3.0%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 238.00
270.00
262.00
262.22
252.47
272.84
280.77
291.04
307.53
306.03
297.95
growth rate 13.5% -3.0% 0.1% -3.7% 8.1% 2.9% 3.7% 5.7% -0.5% -2.6%
Acct.Payable 69.00
86.00
75.00
77.20
83.45
88.96
91.43
105.49
107.34
108.49
122.22
growth rate 24.6% -12.8% 2.9% 8.1% 6.6% 2.8% 15.4% 1.8% 1.1% 12.7%
Cur.Assets 304.00
353.00
361.00
368.72
389.39
422.77
452.86
462.72
493.82
535.62
663.37
growth rate 16.1% 2.3% 2.1% 5.6% 8.6% 7.1% 2.2% 6.7% 8.5% 23.9%
Total Assets 659.00
732.00
769.00
799.68
880.13
960.49
1,015.73
1,059.99
1,112.15
1,254.42
1,414.28
growth rate 11.1% 5.1% 4.0% 10.1% 9.1% 5.8% 4.4% 4.9% 12.8% 12.7%
Cash 32.00
48.00
61.00
67.32
95.67
101.99
119.67
117.18
129.35
169.33
269.18
growth rate 50.0% 27.1% 10.4% 42.1% 6.6% 17.3% -2.1% 10.4% 30.9% 59.0%
Inventory 32.00
32.00
33.00
33.34
35.09
39.02
40.92
46.45
50.70
49.48
63.30
growth rate 0.0% 3.1% 1.0% 5.2% 11.2% 4.9% 13.5% 9.2% -2.4% 27.9%
Cur.Liabilities 140.00
158.00
140.00
152.22
164.14
182.75
170.31
200.44
214.20
251.79
281.01
growth rate 12.9% -11.4% 8.7% 7.8% 11.3% -6.8% 17.7% 6.9% 17.6% 11.6%
Liabilities 305.00
356.00
381.00
403.61
458.26
502.36
526.30
554.10
566.15
674.50
751.43
growth rate 16.7% 7.0% 5.9% 13.5% 9.6% 4.8% 5.3% 2.2% 19.1% 11.4%
LT Debt 151.00
183.00
221.00
232.30
271.98
298.13
331.02
329.98
327.25
364.10
446.55
growth rate 21.2% 20.8% 5.1% 17.1% 9.6% 11.0% -0.3% -0.8% 11.3% 22.7%
Equity 353.90
375.40
388.30
383.50
408.55
442.98
472.05
490.31
527.94
560.56
635.67
growth rate 6.1% 3.4% -1.2% 6.5% 8.4% 6.6% 3.9% 7.7% 6.2% 13.4%
Common Shares 90.70
90.70
90.70
47.16
47.16
47.16
47.16
47.16
47.16
47.16
47.16
growth rate 0.0% 0.0% -48.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 62.00
85.00
85.00
91.76
96.65
84.72
98.38
93.72
94.70
97.71
growth rate 37.1% 0.0% 8.0% 5.3% -12.3% 16.1% -4.7% 1.0% 3.2%
Cash Dividends 7.60
8.60
9.10
9.34
9.46
9.98
10.88
13.61
13.61
15.87
growth rate 13.2% 5.8% 2.6% 1.3% 5.5% 9.1% 25.0% 0.0% 16.7%
Cash From OA 62.00
86.00
87.00
99.70
124.51
92.70
117.96
136.71
132.61
186.39
growth rate 38.7% 1.2% 14.6% 24.9% -25.6% 27.3% 15.9% -3.0% 40.6%
FCF per Share -0.05
-0.02
-0.04
0.04
growth rate 0.0% 0.0% 100.0%
FCF -4.00
-2.00
-3.00
5.00
27.87
7.97
19.58
42.99
37.91
88.68
growth rate 0.0% 0.0% 100.0% 457.3% -71.4% 145.6% 119.5% -11.8% 133.9%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 534.00
567.00
593.00
606.16
650.76
689.33
714.85
768.44
845.41
918.50
986.32
growth rate 6.2% 4.6% 2.2% 7.4% 5.9% 3.7% 7.5% 10.0% 8.7% 7.4%
Op.Income 33.00
32.00
30.00
49.96
58.09
61.54
75.30
68.82
85.63
91.79
130.11
growth rate -3.0% -6.3% 66.5% 16.3% 5.9% 22.4% -8.6% 24.4% 7.2% 41.8%
IBT 52.50
49.80
46.50
45.16
51.43
56.06
69.80
66.86
81.17
80.20
130.18
growth rate -5.1% -6.6% -2.9% 13.9% 9.0% 24.5% -4.2% 21.4% -1.2% 62.3%
Net Income 33.00
32.00
30.00
21.63
29.18
32.44
44.13
40.24
51.88
49.34
103.05
growth rate -3.0% -6.3% -27.9% 34.9% 11.2% 36.0% -8.8% 28.9% -4.9% 108.9%
EPS 0.35
0.34
0.32
0.24
growth rate -2.9% -5.9% -25.0%
Gross Profit 123.00
126.00
126.00
127.99
138.93
144.19
161.54
159.25
179.47
202.95
245.52
growth rate 2.4% 0.0% 1.6% 8.5% 3.8% 12.0% -1.4% 12.7% 13.1% 21.0%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 24.67
29.48
31.14
35.57
35.57
growth rate 19.5% 5.6% 14.2% 0.0%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 306.03
314.33
297.95
297.95
growth rate 1.4% -5.2% 0.0%
Acct.Payable 108.49
113.41
122.22
122.22
growth rate 2.2% 7.8% 0.0%
Cur.Assets 535.62
553.21
663.37
663.37
growth rate 1.6% 19.9% 0.0%
Total Assets 1,254.42
1,274.25
1,414.28
1,414.28
growth rate 0.8% 11.0% 0.0%
Cash 169.33
162.91
269.18
269.18
growth rate -1.9% 65.2% 0.0%
Inventory 49.48
62.84
63.30
63.30
growth rate 12.7% 0.7% 0.0%
Cur.Liabilities 251.79
266.07
281.01
281.01
growth rate 2.8% 5.6% 0.0%
Liabilities 674.50
677.83
751.43
751.43
growth rate 0.3% 10.9% 0.0%
LT Debt 364.10
356.72
446.55
446.55
growth rate -1.0% 25.2% 0.0%
Equity 560.56
560.56
577.26
635.67
635.67
growth rate 0.0% 3.0% 10.1% 0.0%
Common Shares 47.16
47.16
47.16
47.16
growth rate 0.0% 0.0% 0.0%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 25.81
25.98
25.98
growth rate 0.7% 0.0%
Cash Dividends 7.94
7.94
7.94
growth rate 0.0% 0.0%
Cash From OA 51.98
39.01
39.01
growth rate -25.0% 0.0%
FCF 26.17
13.03
13.03
growth rate -50.2% 0.0%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 233.17
239.39
239.10
253.77
253.77
growth rate 2.7% -0.1% 6.1% 0.0%
Op.Income 24.67
29.48
31.14
35.57
35.57
growth rate 19.5% 5.6% 14.2% 0.0%
IBT 19.65
28.68
30.63
36.41
36.41
growth rate 45.9% 6.8% 18.9% 0.0%
Net Income 12.05
19.14
20.66
32.39
32.39
growth rate 58.8% 7.9% 56.8% 0.0%
EPS
growth rate
Gross Profit 52.28
58.19
59.92
64.57
64.57
growth rate 11.3% 3.0% 7.8% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (46.25)

YOY Growth Grade:

E (32.79)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 14.77 14.86 31.66
EPS / Growth 25.2% 1.14

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 8.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 8.1% 16.7% 16.7%
Future PE 14.77 26.58 26.58
Future EPS 2.47 5.30 5.30
Value Price
MOS %
9.03
-46.5%
34.81
106.2%
34.81
106.2%
MOS Price 4.51 17.41 17.41
IRT 9.60 7.37 7.37

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.